Methyl nomilinateCAS# 77887-51-5 |
Quality Control & MSDS
Package In Stock
Number of papers citing our products
| Cas No. | 77887-51-5 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C29H38O10 | M.Wt | 546.6 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Methyl nomilinate Dilution Calculator
Methyl nomilinate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.8295 mL | 9.1475 mL | 18.2949 mL | 36.5898 mL | 45.7373 mL |
| 5 mM | 0.3659 mL | 1.8295 mL | 3.659 mL | 7.318 mL | 9.1475 mL |
| 10 mM | 0.1829 mL | 0.9147 mL | 1.8295 mL | 3.659 mL | 4.5737 mL |
| 50 mM | 0.0366 mL | 0.1829 mL | 0.3659 mL | 0.7318 mL | 0.9147 mL |
| 100 mM | 0.0183 mL | 0.0915 mL | 0.1829 mL | 0.3659 mL | 0.4574 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 1-Phenylethyl beta-D-glucoside
Catalog No.:BCX0051
CAS No.:93199-03-2
- Ganoderiol D
Catalog No.:BCX0050
CAS No.:114567-45-2
- Geissoschizine
Catalog No.:BCX0049
CAS No.:439-66-7
- Taxezopidine H
Catalog No.:BCX0048
CAS No.:205440-23-9
- Calleryanin
Catalog No.:BCX0047
CAS No.:20300-53-2
- Mahuannin B
Catalog No.:BCX0046
CAS No.:82796-37-0
- Symplocoside
Catalog No.:BCX0045
CAS No.:76502-76-6
- Oblongaroside B
Catalog No.:BCX0044
CAS No.:1000889-11-1
- Methyl ganoderate B
Catalog No.:BCX0043
CAS No.:81907-65-5
- Ganoderic acid beta
Catalog No.:BCX0042
CAS No.:217476-76-1
- Ephedrannin D1
Catalog No.:BCX0041
CAS No.:1592431-55-4
- Ganoderic acid GS-2
Catalog No.:BCX0040
CAS No.:1206781-65-8
- Protocatechuic acid 4-O-beta-glucoside
Catalog No.:BCX0053
CAS No.:7361-59-3
- Peltatoside 7-O-beta-glucopyranoside
Catalog No.:BCX0054
CAS No.:813466-12-5
- Tectorigenin 7-O-gentiobioside
Catalog No.:BCX0055
CAS No.:67604-94-8
- Yakuchinone A
Catalog No.:BCX0056
CAS No.:78954-23-1
- Ganoderic acid GS-1
Catalog No.:BCX0057
CAS No.:1206781-64-7
- Ephedrannin A
Catalog No.:BCX0058
CAS No.:82001-39-6
- Nomilinic acid
Catalog No.:BCX0059
CAS No.:35930-20-2
- Oxyphyllol B
Catalog No.:BCX0060
CAS No.:226546-99-2
- Ganosinensic acid C
Catalog No.:BCX0061
CAS No.:2231756-23-1
- 8-Hydroxy-5,7-dimethoxyflavanone
Catalog No.:BCX0062
CAS No.:201230-40-2
- Methyl ganoderate E
Catalog No.:BCX0063
CAS No.:98718-43-5
- Methyl ganoderate F
Catalog No.:BCX0064
CAS No.:98665-08-8
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.[Pubmed:22728232]
Toxicol In Vitro. 2012 Oct;26(7):1216-23.
Limonoids are triterpenoids found in citrus and possess cancer preventive properties in in vitro and in vivo assays. Although several mechanisms for the chemopreventive properties of limonoids have been postulated, the specific mechanisms involved in the anti-cancer effects have not been explored. In the present study, limonoids, including Methyl nomilinate, isoobacunoic acid, isolimonexic acid (ILNA), and limonexic acid (LNA), were purified, identified by LC-MS and NMR spectral data and evaluated for their biological effects on SW480 human colon adenocarcinoma cells. Methyl nomilinate was the most potent inhibitor of cell metabolic activity in MTT and EdU incorporation assays. These limonoids did not affect apoptotic markers such as caspase-3 and PARP, but Methyl nomilinate treatment resulted in significant induction of G0/G1 cell cycle arrest. Furthermore, Methyl nomilinate suppressed CDK4/6 and cyclin D3 and the expression of CDK inhibitors. Taken together, the results suggest inhibition of cell proliferation by Methyl nomilinate occurs due to G1 cell cycle arrest, indicating that Methyl nomilinate has potential as a chemopreventive agent.
Structure-function relationships of citrus limonoids on p38 MAP kinase activity in human aortic smooth muscle cells.[Pubmed:21924259]
Eur J Pharmacol. 2011 Nov 16;670(1):44-9.
Limonoids, abundantly present in citrus fruits, have potential role in reducing risk of different type of cancer. In the present study, we hypothesized that seven structurally different limonoids would involve in inflammatory pathway via modulating p38 MAP kinase activity at various extent in vascular smooth muscle cells. Results demonstrated that the different functional groups containing limonoids had differential effects on the p38 MAP kinase activity in human aortic smooth muscle cells. Among seven limonoids, nomilin exhibited the highest (38%) inhibition of p38 MAP kinase activity, followed by limonin (19%), deacetyl nomilin (19%), and defuran nomilin (17%). While defuran limonin and Methyl nomilinate showed no significant decrease in p38 MAP kinase activity, obacunone significantly increased the p38 MAP kinase activity by 38%. Furthermore, TNF-alpha induced p38 MAP kinase activity in the smooth muscle cells was completely inhibited by nomilin. Thus our data provide the first evidence that nomilin is the potent natural inhibitor for p38 MAP kinase activity in human aortic smooth muscle cells. These data also suggest that a seven-membered A ring with acetoxy group, present in nomilin, seems to be essential for its inhibitory activity on p38 MAP kinase.
Isolation and characterization of new limonoid glycosides from Citrus unshiu peels.[Pubmed:10385977]
Carbohydr Res. 1999 Jan 31;315(1-2):142-7.
Three limonoid glycosides were isolated from Citrus unshiu peels, and their structures were determined based on MS and NMR spectroscopic data as nomilinic acid 17-O-beta-D-glucopyranoside (1), Methyl nomilinate 17-O-beta-D-glucopyranoside (2), and obacunone 17-O-beta-D-glucopyranoside (3). In particular, the location of the sugar moiety was clearly determined by the B/E constant linked scan FABMS method. No limonoid glycosides obtained here were found to have antitumor activity in NCI-H292 and EL-4 cell lines.
